Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) will announce its fourth quarter and full year 2020 financial results on March 16, 2021, after the market closes. The company specializes in endoscopy solutions aimed at improving clinical outcomes and cost-efficiency in diagnosing gastrointestinal conditions. Following the release, management will host a conference call at 4:30 p.m. ET to discuss results and recent developments. A replay will be available on the company's website for 90 days post-event, emphasizing transparency and shareholder communication.
Positive
- Scheduled release of fourth quarter and full year 2020 financial results, indicating transparency.
- Management will provide updates on recent corporate developments during the conference call.
Negative
- None.
News Market Reaction – MOTS
In the trading session that priced this news, MOTS declined 10.42%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year 2020 financial results on Tuesday, March 16, 2021, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
| Conference Call and Webcast | ||
| Date and Time: | Tuesday, March 16th at 4:30 p.m. ET | |
| Domestic: | 877-407-0792 | |
| International: | 201-689-8263 | |
| Passcode: | 13714989 | |
| Webcast: | www.motusgi.com or http://public.viavid.com/index.php?id=142994 | |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com